Literature DB >> 16960467

Characterization of patients with schizophrenia and related psychoses: evaluation of different diagnostic procedures.

Maria Vares1, Andreas Ekholm, Göran C Sedvall, Håkan Hall, Erik G Jönsson.   

Abstract

BACKGROUND: We aimed at estimating the value of structured interviews, medical records and clinical diagnoses for assessing lifetime diagnosis of patients with schizophrenia. In addition, the validity of the Operational Criteria Checklist (OPCRIT) system was analysed. SAMPLING AND METHODS: Swedish patients (n = 73), diagnosed with schizophrenia and related disorders by their treating physician, were scrutinized. Independent research diagnoses according to the Diagnostic and Statistical Manual, ed. 3, revised (DSM-III-R) were obtained by (1) a structured interview; (2) the OPCRIT algorithm, based on record analysis only; (3) the OPCRIT algorithm, based on record and interview analysis, or (4) a separate traditional research diagnosis based on both record and interview analysis. In addition, clinical International Classification of Diseases (ICD) diagnoses, given by the treating physician, were obtained from the case notes. Concordance rates for the different psychosis diagnoses were calculated.
RESULTS: Diagnoses based on interviews only showed poor to fair agreement with the other research diagnoses, but patients diagnosed with schizophrenia or schizophrenic psychoses (i.e. schizophrenia, schizophreniform or schizoaffective disorder) at the interview almost always also obtained a corresponding research diagnosis based on record or combined sources. Diagnoses based on records only showed a good to excellent agreement with diagnoses based on records and interviews. Clinical ICD diagnoses generally displayed poor agreement with the research diagnoses, but 94% of patients ever given a clinical ICD diagnosis of schizophrenic psychosis received a corresponding traditional research diagnosis. OPCRIT diagnoses and independently assigned research diagnoses, based on the same information, displayed excellent concordance.
CONCLUSIONS: Structured interviews performed with Swedish long-term-treated psychosis patients during non-hospitalization are a poor source for the evaluation of psychosis diagnoses, but a good screening instrument for the detection of DSM-III-R schizophrenia. In the investigated population, medical records are a valuable source for diagnostic assessment of psychoses and may serve as a stand-alone procedure in this patient category. Swedish clinical ICD diagnoses have a high positive predictive power identifying DSM-III-R diagnoses of schizophrenic psychoses, indicating validity of register-based research focusing on these diagnoses. The OPCRIT system is a valid tool for assessing DSM-III-R psychosis diagnoses. It should be emphasized that the present conclusions are based on the investigated Swedish psychosis population and cannot be generalized to populations composed of other patient groups or sampled in other settings, with other traditions regarding the use and availability of medical records. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16960467     DOI: 10.1159/000095733

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  14 in total

1.  First- and second-generation antipsychotic drug treatment and subcortical brain morphology in schizophrenia.

Authors:  Kjetil N Jørgensen; Ragnar Nesvåg; Sindre Gunleiksrud; Andrea Raballo; Erik G Jönsson; Ingrid Agartz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-11-07       Impact factor: 5.270

Review 2.  Diagnosis of schizophrenia: consistency across information sources and stability of the condition.

Authors:  Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum
Journal:  Schizophr Res       Date:  2012-04-13       Impact factor: 4.939

3.  Grey and white matter proportional relationships in the cerebellar vermis altered in schizophrenia.

Authors:  Glenn Lawyer; Ragnar Nesvåg; Katarina Varnäs; Gaku Okugawa; Ingrid Agartz
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

4.  Validation of a Population-Based Algorithm to Detect Chronic Psychotic Illness.

Authors:  Paul Kurdyak; Elizabeth Lin; Diane Green; Simone Vigod
Journal:  Can J Psychiatry       Date:  2015-08       Impact factor: 4.356

Review 5.  A review of the reliability and validity of OPCRIT in relation to its use for the routine clinical assessment of mental health patients.

Authors:  Philip J Brittain; Daniel Stahl; James Rucker; Jamie Kawadler; Gunter Schumann
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-09       Impact factor: 4.035

6.  Concomitant medication of psychoses in a lifetime perspective.

Authors:  Maria Vares; Peter Saetre; Pontus Strålin; Sten Levander; Eva Lindström; Erik G Jönsson
Journal:  Hum Psychopharmacol       Date:  2011-06-22       Impact factor: 1.672

7.  Improving risk assessment in schizophrenia: epidemiological investigation of criminal history factors.

Authors:  Katrina Witt; Paul Lichtenstein; Seena Fazel
Journal:  Br J Psychiatry       Date:  2015-02-05       Impact factor: 9.319

8.  Brain expressed microRNAs implicated in schizophrenia etiology.

Authors:  Thomas Hansen; Line Olsen; Morten Lindow; Klaus D Jakobsen; Henrik Ullum; Erik Jonsson; Ole A Andreassen; Srdjan Djurovic; Ingrid Melle; Ingrid Agartz; Håkan Hall; Sally Timm; August G Wang; Thomas Werge
Journal:  PLoS One       Date:  2007-09-12       Impact factor: 3.240

9.  The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples.

Authors:  Line Olsen; Thomas Hansen; Klaus D Jakobsen; Srdjan Djurovic; Ingrid Melle; Ingrid Agartz; Haakan Hall; Henrik Ullum; Sally Timm; August G Wang; Erik G Jönsson; Ole A Andreassen; Thomas Werge
Journal:  BMC Med Genet       Date:  2008-05-06       Impact factor: 2.103

10.  Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.

Authors:  Dimitrios Andreou; Erik Söderman; Tomas Axelsson; Göran C Sedvall; Lars Terenius; Ingrid Agartz; Erik G Jönsson
Journal:  Behav Brain Funct       Date:  2014-07-29       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.